相似文献
1
Improving MM-GB/SA Scoring through the Application of the Variable Dielectric Model.
J Chem Theory Comput. 2011 Dec 13;7(12):3859-3865. doi: 10.1021/ct200565u. Epub 2011 Nov 14.
2
Development and Evaluation of MM/GBSA Based on a Variable Dielectric GB Model for Predicting Protein-Ligand Binding Affinities.
J Chem Inf Model. 2020 Nov 23;60(11):5353-5365. doi: 10.1021/acs.jcim.0c00024. Epub 2020 Mar 20.
3
A Direct Comparison of the MM-GB/SA Scoring Procedure and Free-Energy Perturbation Calculations Using Carbonic Anhydrase as a Test Case: Strengths and Pitfalls of Each Approach.
J Chem Theory Comput. 2011 Jul 12;7(7):2296-306. doi: 10.1021/ct200244p. Epub 2011 Jun 14.
4
Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
J Chem Inf Model. 2010 Apr 26;50(4):547-59. doi: 10.1021/ci900497d.
5
Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking.
Phys Chem Chem Phys. 2016 Aug 10;18(32):22129-39. doi: 10.1039/c6cp03670h.
6
Application of MM-GB/SA and WaterMap to SRC Kinase Inhibitor Potency Prediction.
ACS Med Chem Lett. 2012 Jan 6;3(2):94-9. doi: 10.1021/ml200222u. eCollection 2012 Feb 9.
7
Interpretation of the binding affinities of PTP1B inhibitors with the MM-GB/SA method and the X-score scoring function.
J Chem Inf Model. 2009 Apr;49(4):1033-48. doi: 10.1021/ci8004429.
8
9
farPPI: a webserver for accurate prediction of protein-ligand binding structures for small-molecule PPI inhibitors by MM/PB(GB)SA methods.
Bioinformatics. 2019 May 15;35(10):1777-1779. doi: 10.1093/bioinformatics/bty879.
10
VAD-MM/GBSA: A Variable Atomic Dielectric MM/GBSA Model for Improved Accuracy in Protein-Ligand Binding Free Energy Calculations.
J Chem Inf Model. 2021 Jun 28;61(6):2844-2856. doi: 10.1021/acs.jcim.1c00091. Epub 2021 May 20.
引用本文的文献
1
Insight into the Binding Interaction between PEDCs and hERRγ Utilizing Molecular Docking and Molecular Dynamics Simulations.
Molecules. 2024 Jul 10;29(14):3256. doi: 10.3390/molecules29143256.
2
Revisiting MMPBSA by Adoption of MC-Based Surface Area/Volume, ANI-ML Potentials, and Two-Valued Interior Dielectric Constant.
J Phys Chem B. 2023 May 25;127(20):4415-4429. doi: 10.1021/acs.jpcb.3c00834. Epub 2023 May 12.
3
MM/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4.
J Comput Aided Mol Des. 2023 Apr;37(4):167-182. doi: 10.1007/s10822-023-00499-0. Epub 2023 Mar 17.
4
Anticancer potential of β-sitosterol and oleanolic acid as through inhibition of human estrogenic 17beta-hydroxysteroid dehydrogenase type-1 based on an approach.
RSC Adv. 2022 Jul 13;12(31):20319-20329. doi: 10.1039/d2ra03092f. eCollection 2022 Jul 6.
5
Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein Well-Tempered Metadynamics.
Front Chem. 2022 May 12;10:921695. doi: 10.3389/fchem.2022.921695. eCollection 2022.
6
Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations.
J Biomol Struct Dyn. 2022 Mar;40(5):2010-2023. doi: 10.1080/07391102.2020.1835716. Epub 2020 Oct 21.
7
Heterogeneous Dielectric Implicit Membrane Model for the Calculation of MMPBSA Binding Free Energies.
J Chem Inf Model. 2019 Jun 24;59(6):3041-3056. doi: 10.1021/acs.jcim.9b00363. Epub 2019 Jun 13.
8
The impact of interior dielectric constant and entropic change on HIV-1 complex binding free energy prediction.
Struct Dyn. 2018 Dec 14;5(6):064101. doi: 10.1063/1.5058172. eCollection 2018 Nov.
9
Simulation study of the ability of a computationally-designed peptide to recognize target tRNA and other decoy tRNAs.
Protein Sci. 2016 Dec;25(12):2243-2255. doi: 10.1002/pro.3056. Epub 2016 Oct 7.
10
Adding energy minimization strategy to peptide-design algorithm enables better search for RNA-binding peptides: Redesigned λ N peptide binds boxB RNA.
J Comput Chem. 2016 Oct 15;37(27):2423-35. doi: 10.1002/jcc.24466. Epub 2016 Aug 4.
本文引用的文献
1
Improved Methods for Side Chain and Loop Predictions via the Protein Local Optimization Program: Variable Dielectric Model for Implicitly Improving the Treatment of Polarization Effects.
J Chem Theory Comput. 2007 Nov;3(6):2108-19. doi: 10.1021/ct700166f.
2
Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and Scoring.
J Chem Theory Comput. 2007 May;3(3):1106-19. doi: 10.1021/ct6003406.
3
A Direct Comparison of the MM-GB/SA Scoring Procedure and Free-Energy Perturbation Calculations Using Carbonic Anhydrase as a Test Case: Strengths and Pitfalls of Each Approach.
J Chem Theory Comput. 2011 Jul 12;7(7):2296-306. doi: 10.1021/ct200244p. Epub 2011 Jun 14.
4
Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
ACS Chem Neurosci. 2010 Jun 16;1(6):435-49. doi: 10.1021/cn100008c. Epub 2010 Mar 25.
5
Predicting fragment binding poses using a combined MCSS MM-GBSA approach.
J Chem Inf Model. 2011 May 23;51(5):1092-105. doi: 10.1021/ci100469n. Epub 2011 Apr 29.
6
Contribution of explicit solvent effects to the binding affinity of small-molecule inhibitors in blood coagulation factor serine proteases.
ChemMedChem. 2011 Jun 6;6(6):1049-66. doi: 10.1002/cmdc.201000533. Epub 2011 Apr 19.
7
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.
J Chem Inf Model. 2011 Jan 24;51(1):69-82. doi: 10.1021/ci100275a. Epub 2010 Nov 30.
8
Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
J Chem Inf Model. 2010 Apr 26;50(4):547-59. doi: 10.1021/ci900497d.
9
Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors.
ChemMedChem. 2009 Dec;4(12):1985-9. doi: 10.1002/cmdc.200900386.
10
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia.
J Med Chem. 2009 Aug 27;52(16):5188-96. doi: 10.1021/jm900521k.
Zotero 插件